Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineeredâ„¢ monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors
Titel:
Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineeredâ„¢ monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors
Auteur:
Goel, S. Bauer, R.J. Desai, K. Bulgaru, A. Iqbal, T. Strachan, B.-K. Kim, G. Kaubisch, A. Vanhove, G.F. Goldberg, G. Mani, S.